Natalizumab (Tysabri). - Abstract - Europe PMC
Natalizumab for Multiple Sclerosis | NEJM
Identification and development of new therapeutics for multiple sclerosis: Trends in Pharmacological Sciences
Monoclonal Antibody Therapy in Multiple Sclerosis - Practical Neurology
Natalizumab for the Treatment of Active Crohn's Disease: Results of the ENCORE Trial - Gastroenterology
Biomedicines | Free Full-Text | Monoclonal Antibodies in Multiple Sclerosis: Present and Future | HTML
Addressing the Disease Course - ppt download
Current immunotherapies for multiple sclerosis and neuromyelitis optica spectrum disorders: the similarities and differences
Spanish consensus on the use of natalizumab (Tysabri®) – 2011 | Neurología (English Edition)
Natalizumab - Wikipedia
Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR) - Sabol - 2017 - Cancer Medicine - Wiley Online Library
Natalizumab treatment of multiple sclerosis: new insights | Immunotherapy
Aaron Boster MD on Twitter: "Click to learn how Tysabri (Natalizumab) works in #MS: https://t.co/TUYQqJTzQo #MultipleSclerosis #Tysabri https://t.co/WC7xvLO3EK" / Twitter
Natalizumab (Tysabri) | American Journal of Neuroradiology
Monoclonal antibodies in the treatment of multiple sclerosis: emergence of B-cell-targeted therapies. - Abstract - Europe PMC
References in Getting specific: monoclonal antibodies in multiple sclerosis - The Lancet Neurology
Brain Sciences | Free Full-Text | Clinical Immunological Correlations in Patients with Multiple Sclerosis Treated with Natalizumab
Natalizumab blocks lymphocyte homing in MS. (A) 4 integrin binds to... | Download Scientific Diagram
Treating Multiple Sclerosis With Monoclonal Antibodies
Biomedicines | Free Full-Text | Monoclonal Antibodies in Multiple Sclerosis: Present and Future | HTML
Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring - The Lancet Neurology
Natalizumab | Nature Reviews Drug Discovery
Eosinophilia during natalizumab treatment: Incidence, risk factors and temporal patterns - ScienceDirect
Alpha4 Integrin - an overview | ScienceDirect Topics
Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab | Nature Reviews Drug Discovery
